Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27272 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Mei Jiang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: the Natural Science Foundation of China, Jiangxi Provincial Natural Science Foundation, the major science and technology R & D projects of Jiangxi Province.
Abstract (Originalsprache)
IRF2BP1 breaked in the middle of exon 1 at the c.322 position and fused with RARA intron 2 which is located at 3717 bp upstream of its exon 3. The fusion produced a new intron by forming a paired splicing donor GT at 9 bp downstream of RARA breakpoint and acceptor AG at the 5' end of RARA exon 3. The IRF2BP1::RARA fusion gene leads a fusion transcript involving IRF2BP1 exon 1 and RARA exon 3, linked by a 9-bp fragment derived from RARA intron 2. The patient with IRF2BP1::RARA has same clinical features of APL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Blood Transfusion, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Department of Hematology, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
- Nursing School of Nanchang University, Nanchang, China.
- Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
- Department of Blood Transfusion, Institute of transfusion, Jiangxi Key Laboratory of transfusion, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Förderung
- the Natural Science Foundation of China
- Jiangxi Provincial Natural Science Foundation
- the major science and technology R & D projects of Jiangxi Province
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Jiang, M., Wang, X., Yu, M., Jiang, S., Hong, M., Zhou, Y., Li, F., Liu, H., & Zhang, Z. (2024). Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American Journal of Hematology. https://doi.org/10.1002/ajh.27272
Vancouver
Jiang M, Wang X, Yu M, Jiang S, Hong M, Zhou Y, et al. Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia. American Journal of Hematology. 2024. doi:10.1002/ajh.27272
BibTeX
@article{Jiang2024,
author = {Jiang, Mei and Wang, Xuemei and Yu, Min and Jiang, Shuling and Hong, Miao and Zhou, Yuru and Li, Fei and Liu, Hongxing and Zhang, Zhanglin},
title = {Report of IRF2BP1 as a novel partner of RARA in variant acute promyelocytic leukemia},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27272}
}
EUVIMED